1月4日下午,国足新任主教练邵佳一在广东肇庆召开新闻发布会,这是他自上任以来,第一次以国足新帅的 身份在媒体面前正式亮相。发布会上,邵佳一表示,担任国家队的主教练只是梦想和目标的重要一步,带领 国家队实现球迷多年的梦想,这才是整个团队真正的工作目标。新帅新兵新希望,这次国足能有新气象吗? 记者 尹成君 报道 梦想是圆梦世界杯 媒体见面会上,邵佳一表达了自己担任国足主帅后的理想与愿望。"当我得知成为中国男足国家队主教练 消息的那一刻,感到非常激动和紧张。激动的是,成为国家队主帅是每个教练员的梦想；紧张的是,我也很 清楚身上的这份责任。从官宣到现在已经有两个月的时间了,对于我来讲,始终有一种紧迫感陪伴着我。" 同时,邵佳一也表示,整个团队的工作目标,就是要带领国足打出让国人满意的拼搏精神和成绩,实现国人多 年的梦想。"作为球员,我们能够为国征战,参加世界杯就是我们的最高梦想。作为教练员也一样,我想世 界上任何一个国家队的教练,他的梦想都是冲进世界杯的大门,打世界杯比赛。" 他也很清醒地认识到困难与压力:"我们很清楚中国足球现在所面临的环境以及困难,所以我们必须要踏踏 实实地一步一个脚印,夯实国家队的基础,努力谦虚 ...

2025年4月4日，新希望公告，杨芳女士新任非独立董事。资料显示，杨芳，女，1971年出生，拥有财务 会计学学士学位和工商管理硕士学位，中国注册会计师和中国注册税务师非执业资格，澳洲会计师公会 会员,中国民主建国会成员，现任新希望集团有限公司领导小组成员、首席财务官。2000年-2013年任职 于毕马威华振会计师事务所，担任合伙人；2013-2016年任职于中国化工集团蓝星股份有限公司，担任 总会计师；2016年11月至2020年7月任新希望集团有限公司首席财务官，也曾担任新希望六和股份有限 公司监事、新希望乳业股份有限公司监事长等职务。 12月30日，新希望公告，因个人原因，周伯平先生不再担任非独立董事职务。 根据2024年报数据，剔除独立董事、监事会主席、监事后，新希望共有16位董事和高级管理人员。从年 龄看，新希望董事和高级管理人员平均年龄为51岁，年龄中位数为48岁，其中，非独立董事刘永好年龄 最高为74岁，非独立董事张明贵年龄最小为43岁。 数据显示，近一年，新希望发生董监高变更6人次，具体如下。 2025年4月4日，新希望公告，陶玉岭先生新任总裁及非独立董事。资料显示，陶玉岭，男，华中农业大 学淡 ...

行 农林牧渔 2026 年 01 月 04 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -10% 0% 10% 19% 29% 38% 2025-01 2025-05 2025-09 农林牧渔 沪深300 相关研究报告 《肥猪供给偏紧年前猪价上行，宠物 食品出口环比改善 —行业周报》- 2025.12.28 《年前猪价存在供需双重支撑，蛋鸡 存栏高位淘鸡延续 —行业周报》- 2025.12.21 《腌腊渐入旺季支撑猪价上行，犊牛 价格上行彰显牛周期景气—行业周 报》-2025.12.14 10 牛肉进口"国别配额及配额外加征关税"落地，利 多国内牛价 ——行业周报 chenxueli@kysec.cn 证书编号：S0790520030001 陈雪丽（分析师） 王高展（分析师） wanggaozhan@kysec.cn 证书编号：S0790525070003 周观察：牛肉进口"国别配额及配额外加征关税"落地，利多国内牛价 供需双驱驱动年前猪价中枢上移，据涌益咨询，截至 2025 年 12 月 31 日，全国 生猪均价 12.78 元/公斤，周环比+1.20 元/公斤，同比-3.01 元/公斤。截至 ...

Group 1 - The core viewpoint of the article highlights that New Hope Group has successfully conducted its first self-assessment for senior professional titles in the livestock and veterinary fields, marking a significant step in empowering private enterprises in Sichuan [1][3] - A total of 26 individuals applied for the assessment, with 9 professionals ultimately passing through a rigorous selection process that included material review, on-site defense, expert evaluation, and public announcement [1] - The assessment process was designed to align with the company's strategic direction and core technological needs, ensuring that the selected candidates are both theoretical experts and practical problem solvers [1] Group 2 - Sichuan's initiative to grant senior title assessment rights to private enterprises is part of a broader strategy to enhance the talent evaluation environment and support the development of the private economy [3] - In 2024, Sichuan plans to delegate senior professional title assessment rights for engineering, agriculture, and natural sciences to 17 pilot units, including New Hope Group [3] - New Hope Group has established a closed-loop talent development mechanism that integrates assessment, training, and utilization, supported by a digital management platform for talent tracking and development [2]

Core Viewpoint - The domestic feed industry is entering a phase of stock competition, with ample capacity becoming the norm. In this context, leading companies are accelerating their overseas expansion, which not only shows a clear growth trajectory but also significantly contributes to their profits [3][4]. Group 1: Industry Overview - The domestic feed market is characterized by surplus capacity and insufficient operating rates, leading companies to focus on improving cost-effectiveness and service to capture market share [5]. - The overseas market is viewed as a "growth blue ocean" for leading companies, with significant results already being observed [5][9]. Group 2: Company Strategies and Performance - New Hope (000876.SZ) reported overseas sales of 4.72 million tons in the first three quarters, a year-on-year increase of 21%, with overseas sales contributing 60-70% of total profits despite only accounting for about 30% of total sales [5][9]. - Haida Group (002311.SZ) experienced a remarkable growth rate in its overseas business, with a 40% year-on-year increase in overseas feed sales in the first half of the year, continuing this growth into the third quarter [5][6]. Group 3: Future Plans and Projections - New Hope plans to increase its overseas feed production capacity by approximately 3.5 million tons over the next two to three years, aiming for a total overseas capacity of 10 million tons by 2028 to support a sales target of 9 million tons [6][9]. - Yuehai Feed (001313.SZ) is also expanding its overseas market, with a recent project in Vietnam generating over 80,000 tons in orders during its launch event [6][9]. - Haida Group is planning to spin off its subsidiary Haida Holdings for a public listing in Hong Kong, which is expected to help achieve its goal of 7.2 million tons in overseas feed sales by 2030 [7][9]. Group 4: Market Potential - The overseas market is seen as a blank slate for domestic feed companies, particularly in regions like Southeast Asia and Africa, where there is a strong demand for high-quality feed products to improve farming efficiency [9]. - The profit margins in overseas markets are expected to be higher than in domestic markets, with some companies reporting that overseas sales account for a significant portion of their profits [9].

Group 1 - The core viewpoint of the articles highlights the emergence of a new phase in the real estate market, characterized by extreme scarcity and asset value differentiation, as evidenced by the record-breaking sales of luxury properties in Shenzhen and Chengdu [3][5][27] - In Shenzhen, the project Shenzhen Bay Luanxi achieved sales of 13 billion yuan on its opening day, setting a national record for single project sales in 2025, while another project, CITIC Xinyue Bay, sold over 10 billion yuan within two hours of its launch [1][2] - The success of these projects signals a shift towards pricing based on super scarcity and asset attributes, indicating that properties in highly sought-after areas are becoming status symbols for elite buyers [5][27] Group 2 - The upcoming project New Hope D10 Wangjiang in Chengdu is positioned as a significant offering for high-end buyers, leveraging the city's rich historical context and unique geographical advantages [8][12][26] - The project is set to include a five-star hotel and a museum, aiming to create a high-end living experience that combines luxury services with cultural significance, thus enhancing its appeal to affluent buyers [18][25] - The real estate market in Chengdu is expected to see a surge in high-end transactions, with over 3,000 new homes priced above 10 million yuan anticipated in 2025, indicating a competitive landscape for luxury properties [27][28]

Core Viewpoint - The Central Rural Work Conference held on December 29-30 in Beijing analyzed the current situation and challenges facing the "three rural issues" and outlined the work plan for 2026, emphasizing the importance of agricultural modernization for China's overall modernization [2] Group 1 - The conference highlighted the necessity to accelerate the construction of a strong agricultural nation, indicating its critical role in the broader context of Chinese modernization [2]

Core Insights - Oligonucleotide therapies are emerging as a significant breakthrough in the treatment of rare diseases, with over a dozen therapies approved globally and hundreds in clinical research, promising to benefit more patients in the future [1][14][15] Industry Developments - The global landscape has seen more than ten oligonucleotide therapies approved for rare diseases, providing new treatment options for conditions such as Amyotrophic Lateral Sclerosis (ALS), Duchenne Muscular Dystrophy (DMD), and Hemophilia [1][14] - There are currently over a hundred oligonucleotide therapies in clinical development targeting various rare diseases, including siRNA and antisense oligonucleotide (ASO) therapies [2][14] Recent Approvals and Innovations - In August, Ionis Pharmaceuticals received FDA approval for the LICA drug Dawnzera (donidalorsen) for preventing hereditary angioedema (HAE) attacks in patients aged 12 and older, marking it as the first RNA-targeted drug for HAE [4][18] - Ionis Pharmaceuticals and Sobi announced the approval of ASO drug Tryngolza (olezarsen) in the EU for treating genetically confirmed familial chylomicronemia syndrome (FCS) [4][19] - Alnylam Pharmaceuticals' siRNA therapy Amvuttra (vutrisiran) was approved by the FDA in March for treating patients with transthyretin amyloidosis with cardiomyopathy [5][19] Clinical Trial Progress - NS Pharma reported positive results from the long-term extension study of ASO therapy brogidirsen for DMD, showing effective exon 44 skipping and stable maintenance of motor function in patients [7][21] - RIBOMIC's umedaptanib pegol showed promising results in a Phase 2 trial for achondroplasia in children, with many patients experiencing improved height growth rates [7][21] - Ionis Pharmaceuticals' ASO therapy zilganersen demonstrated significant results in stabilizing walking speed in Alexander disease patients, with plans for a new drug application to the FDA in 2026 [8][22] WuXi TIDES Platform - WuXi TIDES has established an integrated solution for oligonucleotide and peptide therapies, covering custom synthesis, conjugation, process development, and CMC, facilitating the transition of innovative projects into clinical stages [1][11][26] - The platform offers comprehensive CRDMO services from drug discovery to commercial production, supporting high-throughput synthesis and custom synthesis for various oligonucleotides [11][26][27] Future Outlook - The company aims to continue leveraging its integrated CRDMO model to empower the development of various new drugs, including oligonucleotide therapies, to bring more effective treatments to patients [12][27]

S0340513040002 电话：0769-22119462 邮箱：whm2@dgzq.com.cn 2025 年 12 月 30 日 生猪养殖行业深度报告 投资要点： 本报告的风险等级为中高风险。 本报告的信息均来自已公开信息，关于信息的准确性与完整性，建议投资者谨慎判断，据此入市，风险自担。 请务必阅读末页声明。 资料来源：同花顺 iFinD，东莞证券研 究所 超配（维持） 关注产能去化 布局盈利拐点 深 农林牧渔行业 | 图 | 27：SW 生猪养殖板块单季营收同比增速（%） 12 | | | --- | --- | --- | | 图 | 28：SW 生猪养殖板块单季归母净利润同比增速（%） 12 | | | 图 29：SW | 生猪养殖板块单季度毛利率净利率（%） 13 | | | 图 | 30：SW 生猪养殖板块单季度期间费用率（%） 13 | | | 图 | 31：我国生猪养殖年出栏户数占比（%） | 14 | | 图 | 32：我国生猪行业规模化程度（%） | 14 | 推荐 分析师：魏红梅 SAC 执业证书编号： 我国是全球最大的生猪及猪肉产需国。根据美国农业部2025年4 月份《牲畜和家 ...

Core Viewpoint - The aquaculture sector experienced a rise of 1.15% on December 30, with Jingji Zhino leading the gains, while the overall market showed mixed results with the Shanghai Composite Index closing at 3965.12, unchanged, and the Shenzhen Component Index at 13604.07, up by 0.49% [1]. Group 1: Stock Performance - Jingji Zhino (000048) closed at 17.23, up by 5.90%, with a trading volume of 453,500 shares and a transaction value of 766 million yuan [1]. - Other notable performers included: - Shennong Group (605296) at 29.45, up by 2.08% [1]. - Muyuan Foods (002714) at 50.89, up by 1.98% [1]. - Lihua Co. (300761) at 20.78, up by 1.27% [1]. - Wens Foodstuff Group (300498) at 17.12, up by 1.18% [1]. Group 2: Capital Flow - The aquaculture sector saw a net outflow of 21.95 million yuan from institutional investors, while retail investors contributed a net inflow of 153 million yuan [2]. - The capital flow for key stocks included: - Muyuan Foods (002714) had a net inflow of 1.29 billion yuan from institutional investors, but a net outflow of 104 million yuan from retail investors [3]. - Jingji Zhino (000048) experienced a net inflow of 32.34 million yuan from institutional investors and a net inflow of 43.92 million yuan from retail investors [3]. - New Hope (000876) had a net inflow of 11.87 million yuan from institutional investors [3].